Literature DB >> 12683933

Thyrotropin-releasing hormone receptors -- similarities and differences.

Y Sun1, X Lu, M C Gershengorn.   

Abstract

Thyrotropin-releasing hormone (TRH) initiates its effects by interacting with cell-surface membrane receptors. Two G protein-coupled receptors for TRH, TRH receptor type 1 (TRH-R1) and TRH receptor type 2 (TRH-R2), have been cloned from mammals. In this review, we compare TRH-R1 and TRH-R2 with regard to their tIssue distribution, binding affinities for TRH and TRH analogs, basal and activated signaling activities and characteristics of internalization. TRH-R1 and TRH-R2 are distributed differently in the brain and peripheral tIssues, but exhibit indistinguishable binding affinities for TRH and TRH analogs. Although they both can be stimulated by TRH to similar maximal signaling levels, TRH-R2 exhibits higher basal signaling activity and is more rapidly internalized than TRH-R1. These differences in signaling and internalization properties are probably important in the distinct parts that TRH-R1 and TRH-R2 may play in mammalian physiology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12683933     DOI: 10.1677/jme.0.0300087

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  40 in total

Review 1.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

2.  Persistent signaling by thyrotropin-releasing hormone receptors correlates with G-protein and receptor levels.

Authors:  Alisa Boutin; Michael D Allen; Susanne Neumann; Marvin C Gershengorn
Journal:  FASEB J       Date:  2012-05-16       Impact factor: 5.191

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

4.  Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 5.  Role of ERG1 isoforms in modulation of ERG1 channel trafficking and function.

Authors:  Anders Peter Larsen
Journal:  Pflugers Arch       Date:  2010-06-24       Impact factor: 3.657

6.  Penetration of thyroliberin in the blood and brain regions at intranasal or intravenous administration.

Authors:  K V Shevchenko; T V Vyunova; A S Radilov; L A Andreeva; I Yu Nagaev; V P Shevchenko; V R Rembovsky; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2016-01-05       Impact factor: 0.788

7.  Thyrotropin-releasing hormone increases GABA release in rat hippocampus.

Authors:  Pan-Yue Deng; James E Porter; Hee-Sup Shin; Saobo Lei
Journal:  J Physiol       Date:  2006-09-21       Impact factor: 5.182

8.  Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Authors:  John P Dougherty; Brian S Wolff; Mary J Cullen; Leorey N Saligan; Marvin C Gershengorn
Journal:  Pharmacol Res       Date:  2017-07-15       Impact factor: 7.658

9.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

10.  TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes.

Authors:  Yuhua Sun; Bojana Zupan; Bruce M Raaka; Miklos Toth; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.